Eicosapentaenoic and docosahexaenoic acid ethyl esters differentially enhance B-cell activity in murine obesity

Journal of Lipid Research

Volumn 55, Issue 7, 2014, Pages 1420-1422

  Teague, Heather ^a   Harris, Mitchel ^a   Fenton, Jenifer ^b   Lallemand, Perrine ^a   Shewchuk, Brian M ^a   Shaikh, Saame Raza ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

High fat diets; Immunity; Metabolism; N 3 polyunsaturated fatty acids

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOIC ACID ETHYL ESTER; FATTY ACID ESTER; GLUCOSE; ICOSAPENTAENOIC ACID; ICOSAPENTAENOIC ACID ETHYL ESTER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INSULIN; INTERLEUKIN 10; LINOLEIC ACID; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; ARACHIDIC ACID; IL10 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CLEARANCE; CONTROLLED STUDY; CYTOKINE RELEASE; DIET RESTRICTION; EX VIVO STUDY; FAT MASS; FEMALE; GLUCOSE METABOLISM; HAMSTER; LIPID COMPOSITION; LIPID MEMBRANE; LYMPHOCYTE FUNCTION; MALE; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; SPLEEN CELL; ANIMAL; IMMUNOLOGY; PATHOLOGY;

ANIMALS; B-LYMPHOCYTES; DOCOSAHEXAENOIC ACIDS; EICOSANOIC ACIDS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; INTERLEUKIN-10; MALE; MICE; OBESITY;

EID: 84904009130     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M049809     Document Type: Article

References (61)

1. Kiecolt-Glaser, J. K., M. A. Belury, R. Andridge, W. B. Malarkey, B. S. Hwang, and R. Glaser. 2012. Omega-3 supplementation lowers infl ammation in healthy middle-aged and older adults: a randomized controlled trial. Brain Behav. Immun. 26: 988-995.
2. Itariu, B. K., M. Zeyda, E. E. Hochbrugger, A. Neuhofer, G. Prager, K. Schindler, A. Bohdjalian, D. Mascher, S. Vangala, M. Schranz, et al. 2012. Long-chain n-3 PUFAs reduce adipose tissue and systemic infl ammation in severely obese nondiabetic patients: a randomized controlled trial. Am. J. Clin. Nutr. 96: 1137-1149.
3. Spencer, M., B. S. Finlin, R. Unal, B. Zhu, A. J. Morris, L. R. Shipp, J. Lee, R. G. Walton, A. Adu, R. Erfani, et al. 2013. Omega-3 fatty acids reduce adipose tissue macrophages in human subjects with insulin resistance. Diabetes. 62: 1709-1717.
4. Dayspring, T. D. 2011. Understanding hypertriglyceridemia in women: clinical impact and management with prescription omega-3-acid ethyl esters. Int. J. Womens Health. 3: 87-97.
5. Maki, K. C., A. L. Lawless, K. M. Kelley, M. R. Dicklin, V. N. Kaden, A. L. Schild, T. M. Rains, and J. W. Marshall. 2011. Effects of prescription omega-3-acid ethyl esters on fasting lipid profile in subjects with primary hypercholesterolemia. J. Cardiovasc. Pharmacol. 57: 489-494.
6. Shaikh, S. R., C. A. Jolly, and R. S. Chapkin. 2012. n-3 Polyunsaturated fatty acids exert immunomodulatory effects on lymphocytes by targeting plasma membrane molecular organization. Mol. Aspects Med. 33: 46-54.
7. Monk, J. M., T. Y. Hou, H. F. Turk, B. Weeks, C. Wu, D. N. McMurray, and R. S. Chapkin. 2012. Dietary n-3 polyunsaturated fatty acids (PUFA) decrease obesity-associated Th17 cell-mediated infl ammation during colitis. PLoS ONE. 7: e49739.
8. Oh, D. Y., S. Talukdar, E. J. Bae, T. Imamura, H. Morinaga, W. Fan, P. Li, W. J. Lu, S. M. Watkins, and J. M. Olefsky. 2010. GPR120 is an omega-3 fatty acid receptor mediating potent anti-infl ammatory and insulin-sensitizing effects. Cell. 142: 687-698.
9. Sheridan, P. A., H. A. Paich, J. Handy, E. A. Karlsson, M. G. Hudgens, A. B. Sammon, L. A. Holland, S. Weir, T. L. Noah, and M. A. Beck. 2012. Obesity is associated with impaired immune response to infl u-enza vaccination in humans. Int. J. Obes. (Lond). 36: 1072-1077.
10. Teague, H., C. J. Fhaner, M. Harris, D. M. Duriancik, G. E. Reid, and S. R. Shaikh. 2013. n-3 PUFAs enhance the frequency of murine B-cell subsets and restore the impairment of antibody production to a T-independent antigen in obesity. J. Lipid Res. 54: 3130-3138.
11. Rockett, B. D., H. Teague, M. Harris, M. Melton, J. Williams, S. R. Wassall, and S. R. Shaikh. 2012. Fish oil increases raft size and membrane order of B cells accompanied by differential effects on function. J. Lipid Res. 53: 674-685.
12. Rockett, B. D., M. Salameh, K. Carraway, K. Morrison, and S. R. Shaikh. 2010. n-3 PUFA improves fatty acid composition, prevents palmitate-induced apoptosis, and differentially modifies B cell cy-tokine secretion in vitro and ex vivo. J. Lipid Res. 51: 1284-1297.
13. Gurzell, E. A., H. Teague, M. Harris, J. Clinthorne, S. R. Shaikh, and J. I. Fenton. 2013. DHA-enriched fish oil targets B cell lipid microdomains and enhances ex vivo and in vivo B cell function. J. Leukoc. Biol. 93: 463-470.
14. Tomasdottir, V., S. Thorleifsdottir, A. Vikingsson, I. Hardardottir, and J. Freysdottir. 2014. Dietary omega-3 fatty acids enhance the B1 but not the B2 cell immune response in mice with antigen-induced peritonitis. J. Nutr. Biochem. 25: 111-117.
15. Strobel, C., G. Jahreis, and K. Kuhnt. 2012. Survey of n-3 and n-6 polyunsaturated fatty acids in fish and fish products. Lipids Health Dis. 11: 144.
16. Kalupahana, N. S., K. J. Claycombe, and N. Moustaid-Moussa. 2011. (n-3) Fatty acids alleviate adipose tissue infl ammation and insulin resistance: mechanistic insights. Adv. Nutr. 2: 304-316.
17. Miles, E. A., and P. C. Calder. 2012. Infl uence of marine n-3 poly-unsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br. J. Nutr. 107 (Suppl 2): S171-S184.
18. Pillai, S., and A. Cariappa. 2009. The follicular versus marginal zone B lymphocyte cell fate decision. Nat. Rev. Immunol. 9: 767-777.
19. Baumgarth, N. 2011. The double life of a B-1 cell: self-reactivity selects for protective effector functions. Nat. Rev. Immunol. 11: 34-46.
20. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
21. Gaus, K., T. Zech, and T. Harder. 2006. Visualizing membrane mi-crodomains by Laurdan 2-photon microscopy. Mol. Membr. Biol. 23: 41-48.
22. Shaikh, S. R., and M. Edidin. 2007. Immunosuppressive effects of polyunsaturated fatty acids on antigen presentation by human leukocyte antigen class I molecules. J. Lipid Res. 48: 127-138.
23. Kwik, J., S. Boyle, D. Fooksman, L. Margolis, M. P. Sheetz, and M. Edidin. 2003. Membrane cholesterol, lateral mobility, and the phosphatidylinositol 4, 5-bisphosphate-dependent organization of cell actin. Proc. Natl. Acad. Sci. USA. 100: 13964-13969.
24. Grönwall, C., J. Vas, and G. J. Silverman. 2012. Protective roles of natural IgM antibodies. Front. Immunol. 3: 66.
25. Kim, W., N. A. Khan, D. N. McMurray, I. A. Prior, N. Wang, and R. S. Chapkin. 2010. Regulatory activity of polyunsaturated fatty acids in T-cell signaling. Prog. Lipid Res. 49: 250-261.
26. Kratz, M., J. N. Kuzma, D. K. Hagman, B. van Yserloo, C. C. Matthys, H. S. Callahan, and D. S. Weigle. 2013. n3 PUFAs do not affect adipose tissue infl ammation in overweight to moderately obese men and women. J. Nutr. 143: 1340-1347.
27. Monk, J. M., Q. Jia, E. Callaway, B. Weeks, R. C. Alaniz, D. N. McMurray, and R. S. Chapkin. 2012. Th17 cell accumulation is decreased during chronic experimental colitis by (n-3) PUFA in Fat-1 mice. J. Nutr. 142: 117-124.
28. Teague, H., B. D. Rockett, M. Harris, D. A. Brown, and S. R. Shaikh. 2013. Dendritic cell activation, phagocytosis and CD69 expression on cognate T cells are suppressed by n-3 long-chain polyunsatu-rated fatty acids. Immunology. 139: 386-394.
29. Hou, T. Y., J. M. Monk, Y. Y. Fan, R. Barhoumi, Y. Q. Chen, G. M. Rivera, D. N. McMurray, and R. S. Chapkin. 2012. n-3 polyunsatu-rated fatty acids suppress phosphatidylinositol 4, 5-bisphosphate-de-pendent actin remodelling during CD4+ T-cell activation. Biochem. J. 443: 27-37.
30. Hao, W., O. Y. Wong, X. Liu, P. Lee, Y. Chen, and K. K. Wong. 2010. Omega-3 fatty acids suppress infl ammatory cytokine production by macrophages and hepatocytes. J. Pediatr. Surg. 45: 2412-2418.
31. Zeyda, M., M. D. Saemann, K. M. Stuhlmeier, D. G. Mascher, P. N. Nowotny, G. J. Zlabinger, W. Waldhausl, and T. M. Stulnig. 2005. Polyunsaturated fatty acids block dendritic cell activation and function independently of NF-kappaB activation. J. Biol. Chem. 280: 14293-14301.
32. Sperling, R. I. 1998. The effects of dietary n-3 polyunsaturated fatty acids on neutrophils. Proc. Nutr. Soc. 57: 527-534.
33. Nelson, S. D., and M. A. Munger. 2013. Icosapent ethyl for treatment of elevated triglyceride levels. Ann. Pharmacother. 47: 1517-1523.
34. Kaminski, D. A., and J. Stavnezer. 2006. Enhanced IgA class switch-ing in marginal zone and B1 B cells relative to follicular/B2 B cells. J. Immunol. 177: 6025-6029.
35. Olson, M. V., Y. C. Liu, B. Dangi, J. Paul Zimmer, N. Salem, Jr., and J. M. Nauroth. 2013. Docosahexaenoic acid reduces infl ammation and joint destruction in mice with collagen-induced arthritis. Infl amm. Res. 62: 1003-1013.
36. Notley, C. A., M. A. Brown, G. P. Wright, and M. R. Ehrenstein. 2011. Natural IgM is required for suppression of infl ammatory arthritis by apoptotic cells. J. Immunol. 186: 4967-4972.
37. Nishimura, S., I. Manabe, S. Takaki, M. Nagasaki, M. Otsu, H. Yamashita, J. Sugita, K. Yoshimura, K. Eto, I. Komuro, et al. 2013. Adipose natural regulatory B cells negatively control adipose tissue infl ammation. Cell Metab. 18: 759-766.
38. Ulven, S. M., B. Kirkhus, A. Lamglait, S. Basu, E. Elind, T. Haider, K. Berge, H. Vik, and J. I. Pedersen. 2011. Metabolic effects of krill oil are essentially similar to those of fish oil but at lower dose of EPA and DHA, in healthy volunteers. Lipids. 46: 37-46.
39. Xin, W., W. Wei, and X. Li. 2012. Effects of fish oil supplementation on infl ammatory markers in chronic heart failure: a meta-analysis of randomized controlled trials. BMC Cardiovasc. Disord. 12: 77.
40. Johansen, O., I. Seljefl ot, A. T. Hostmark, and H. Arnesen. 1999. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 19: 1681-1686.
41. Itariu, B. K., M. Zeyda, L. Leitner, R. Marculescu, and T. M. Stulnig. 2013. Treatment with n-3 polyunsaturated fatty acids overcomes the inverse association of vitamin D deficiency with infl ammation in severely obese patients: a randomized controlled trial. PLoS ONE. 8: e54634.
42. Kawasaki, K., M. Abe, F. Tada, Y. Tokumoto, S. Chen, T. Miyake, S. Furukawa, B. Matsuura, Y. Hiasa, and M. Onji. 2013. Blockade of B-cell-activating factor signaling enhances hepatic steatosis induced by a high-fat diet and improves insulin sensitivity. Lab. Invest. 93: 311-321.
43. Winer, D. A., S. Winer, L. Shen, P. P. Wadia, J. Yantha, G. Paltser, H. Tsui, P. Wu, M. G. Davidson, M. N. Alonso, et al. 2011. B cells promote insulin resistance through modulation of T cells and production of pathogenic IgG antibodies. Nat. Med. 17: 610-617.
44. DeFuria, J., A. C. Belkina, M. Jagannathan-Bogdan, J. Snyder-Cappione, J. D. Carr, Y. R. Nersesova, D. Markham, K. J. Strissel, A. A. Watkins, M. Zhu, et al. 2013. B cells promote infl ammation in obesity and type 2 diabetes through regulation of T-cell function and an infl ammatory cytokine profile. Proc. Natl. Acad. Sci. USA. 110: 5133-5138.
45. Sacks, F. M., G. A. Bray, V. J. Carey, S. R. Smith, D. H. Ryan, S. D. Anton, K. McManus, C. M. Champagne, L. M. Bishop, N. Laranjo, et al. 2009. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N. Engl. J. Med. 360: 859-873.
46. Turchini, G. M., P. D. Nichols, C. Barrow, and A. J. Sinclair. 2012. Jumping on the omega-3 bandwagon: distinguishing the role of long-chain and short-chain omega-3 fatty acids. Crit. Rev. Food Sci. Nutr. 52: 795-803.
47. Yanaba, K., J. D. Bouaziz, T. Matsushita, C. M. Magro, E. W. St Clair, and T. F. Tedder. 2008. B-lymphocyte contributions to human autoimmune disease. Immunol. Rev. 223: 284-299.
48. Mariño, E., and S. T. Grey. 2012. B cells as effectors and regulators of autoimmunity. Autoimmunity. 45: 377-387.
49. Karlsson, E. A., and M. A. Beck. 2010. The burden of obesity on infectious disease. Exp. Biol. Med. (Maywood). 235: 1412-1424.
50. Baumgarth, N., O. C. Herman, G. C. Jager, L. Brown, and L. A. Herzenberg. 1999. Innate and acquired humoral immunities to in-fl uenza virus are mediated by distinct arms of the immune system. Proc. Natl. Acad. Sci. USA. 96: 2250-2255.
51. Cesena, F. H., P. C. Dimayuga, J. Yano, X. Zhao, J. Kirzner, J. Zhou, L. F. Chan, W. M. Lio, B. Cercek, P. K. Shah, et al. 2012. Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE-/-mice. Atherosclerosis. 220: 59-65.
52. Werwitzke, S., D. Trick, K. Kamino, T. Matthias, K. Kniesch, B. Schlegelberger, R. E. Schmidt, and T. Witte. 2005. Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the (NZB x NZW)F1 mouse. Arthritis Rheum. 52: 3629-3638.
53. de Faire, U., and J. Frostegard. 2009. Natural antibodies against phosphorylcholine in cardiovascular disease. Ann. N. Y. Acad. Sci. 1173: 292-300.
54. Kroese, F. G., E. C. Butcher, A. M. Stall, P. A. Lalor, S. Adams, and L. A. Herzenberg. 1989. Many of the IgA producing plasma cells in murine gut are derived from self-replenishing precursors in the peritoneal cavity. Int. Immunol. 1: 75-84.
55. Kim, W., Y. Y. Fan, R. Barhoumi, R. Smith, D. N. McMurray, and R. S. Chapkin. 2008. N-3 polyunsaturated fatty acids suppress the localization and activation of signaling proteins at the immunologi-cal synapse in murine CD4+ T cells by affecting lipid raft formation. J. Immunol. 181: 6236-6243.
56. Williams, J. A., S. E. Batten, M. Harris, B. D. Rockett, S. R. Shaikh, W. Stillwell, and S. R. Wassall. 2012. Docosahexaenoic and eicosa-pentaenoic acids segregate differently between raft and nonraft domains. Biophys. J. 103: 228-237.
57. Shaikh, S. R., and H. Teague. 2012. N-3 fatty acids and membrane microdomains: from model membranes to lymphocyte function. Prostaglandins Leukot. Essent. Fatty Acids. 87: 205-208.
58. Shaikh, S. R. 2012. Biophysical and biochemical mechanisms by which dietary n-3 polyunsaturated fatty acids from fish oil disrupt membrane lipid rafts. J. Nutr. Biochem. 23: 101-105.
59. Teague, H., R. Ross, M. Harris, D. C. Mitchell, and S. R. Shaikh. 2013. DHA-fl uorescent probe is sensitive to membrane order and reveals molecular adaptation of DHA in ordered lipid microdomains. J. Nutr. Biochem. 24: 188-195.
60. Rajamoorthi, K., H. I. Petrache, T. J. McIntosh, and M. F. Brown. 2005. Packing and viscoelasticity of polyunsaturated omega-3 and omega-6 lipid bilayers as seen by (2)H NMR and X-ray diffraction. J. Am. Chem. Soc. 127: 1576-1588.
61. Mills, K. H. 2011. TLR-dependent T cell activation in autoimmu-nity. Nat. Rev. Immunol. 11: 807-822.